Critical comments

Maturitas

Volumn 44, Issue 1, 2003, Pages 11-18

  Genazzani, Andrea Riccardo ^a   Gambacciani, Marco ^a   Van Der Mooren, Marius Jan ^b   Speroff, Leon ^c   Dören, Martina ^d   Pines, Amos ^e,f  

^a UNIVERSITY OF PISA   (Italy)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^f Menopause Clinic   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; HORMONE;

BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DECISION MAKING; FEMALE; HEALTH; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSE; NOTE; PHYSICIAN ATTITUDE;

ATTITUDE OF HEALTH PERSONNEL; BREAST NEOPLASMS; CORONARY DISEASE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 0037472911     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(02)00334-1     Document Type: Note

References (0)